Developer docs
API playgroundTry for free, no card

Search company profiles

Medvance

Full company profile

uuid000n7gy

Namestring
Medvance
Legal namestring
Nextep
Websiteurl
medvance.eu
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Medvance is a European healthcare consultancy group headquartered in Paris, France, providing market access and public affairs services to pharmaceutical, biotechnology, and medical device companies. Founded in 2017 and operating under the French SARL legal entity Nextep (established 1999 by Guillaume Bouchara), the firm is structured as an integrated network of locally grounded member firms spanning nine European markets: France, Italy, the United Kingdom, Germany, Spain, Belgium, Portugal, the Netherlands, and Luxembourg. The 80-person team enables clients to contract with MEDVANCE as a single legal entity while accessing country-specific expertise through member firms including Nextep (France), Intexo Società Benefit (Italy), and Remap Consulting (UK).

The company delivers two core service lines. Market Access Services encompass European HTA support, strategic pricing advice, local HTA submission and negotiation, reimbursement submissions, health economics analyses (systematic literature reviews, network meta-analyses), clinical engagement, advisory board facilitation, payer research, real-world data studies, and medical writing. Public Affairs Services cover health policy advocacy, political influencing, patient advocacy, stakeholder outreach, campaign and coalition building, and policy intelligence and monitoring. Delivery is anchored by senior partners with 20+ years of healthcare experience, including prior roles at Pfizer, Ferring Pharmaceuticals, GSK, IMS Consulting, and Ambrosetti.

Medvance generates revenue through professional services consulting engagements on a B2B quote-based pricing model, selling to enterprise clients across pharmaceutical, biotech, and medical device verticals. The go-to-market motion is direct enterprise field sales, supplemented by thought leadership at industry conferences (ISPOR Europe, BIO International), peer-reviewed publications and posters, and a LinkedIn presence. The firm is privately held with no disclosed external funding or M&A activity in the input data.

Short descriptiontext

Medvance is a European healthcare consultancy group providing market access and public affairs services to pharmaceutical, biotechnology, and medical device companies across nine European countries via an integrated network of locally grounded member firms.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersParis, France
HQ citystring
Paris
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare market access, pharmaceutical consulting, HTA support services, public affairs consulting, reimbursement strategy
Industry1 code
PRIMARYHLAIAKAL
Access Policy, Advocacy & Stakeholder Management
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing
SIC code1 code
  • Services-Health Services8000
Product category
Healthcare Market Access Consulting
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Professional Services Consulting
TypeProfessional Services
Description

Provides consulting services for market access, HTA support, pricing advice, and public affairs for pharmaceutical, biotech and medical device companies across European markets.

medvance.eu
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Medvance is a European-wide consultancy group providing market access and public affairs consulting services to pharmaceutical, biotechnology and medical device companies. Market Access services cover European HTA support, access strategy, pricing advice, reimbursement submission, health economics, systematic literature review, network meta-analysis and real world data studies. Public Affairs services cover health policy advocacy, campaign building, patient advocacy and stakeholder outreach across nine European markets through a network of locally grounded member firms.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Medvance is a European-wide consultancy group that offers two primary service offerings: Market Access Services and Public Affairs Services. The Market Access Services provide comprehensive support including European HTA support, strategic pricing advice, reimbursement submission, health economics, and real world data studies. The Public Affairs Services focus on health policy, political influencing, patient advocacy, and stakeholder outreach. These services work together to address the market access and public affairs needs of pharmaceutical, biotech, and medical devices companies across European markets.

Product and service1 record
1Market Access Services
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeOthers
Description

Parent legal entity and founding member of MEDVANCE. Based in Paris, provides market access and public affairs consultancy services. Guillaume Bouchara founded Nextep in 1999 and serves as Publication Director.

2Intexo Società Benefit
Strategic tierCoreTypeOthers
Description

Italian member firm of MEDVANCE network. Mariangela Prada serves as CEO and Partner at Intexo, bringing 20 years of healthcare market access experience.

medvance.eu
Strategic tierCoreTypeOthers
Description

UK-based member firm. Graham Foxon co-founded Remap Consulting in 2014, specializing in pricing, health economics and market access optimization with over 20 years pharmaceutical experience.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Specialist consulting firm focused exclusively on biopharma market access, pricing and commercial strategy. Highly comparable to Medvance in service scope and customer base, with deeper US presence and similar EU mid-cap client focus.

TypeBroad incumbent
Description

CRA's Life Sciences practice provides pricing, market access, HEOR and commercial strategy to global pharma. A direct competitor for EU HTA and pricing engagements, though CRA covers a broader range of industries and services beyond healthcare.

TypeBroad incumbent
Description

PPD/Evidera is a dedicated HEOR, market access and real-world evidence consultancy serving pharma and biotech across Europe and globally. Directly competes with Medvance on HTA submissions, HEOR modeling and RWE studies, now operating under Thermo Fisher.

TypeBroad incumbent
Description

Top-tier strategy consultancy with a dedicated pharma/biotech practice advising on market access, pricing and public affairs at the executive level. Larger and broader than Medvance, but competes for the same senior pharma strategy budgets.

TypeDirect peer
Description

UK-based market access and pricing consultancy serving pharma, biotech and medtech with EU and global coverage. Direct niche peer competing for the same HTA, pricing and value communication mandates Medvance serves.

TypeBroad incumbent
Description

Global CRO and healthcare consulting giant offering HEOR, market access, HTA and real-world evidence services to pharma. Overlaps directly with Medvance's market access offering but as part of a much broader portfolio spanning clinical, commercial and technology services.

TypeDirect peer
Description

Specialist pricing, market access and HEOR consultancy serving pharma and biotech globally. Closely comparable service mix to Medvance, with comparable scale and a similar focus on cross-border pricing and HTA strategy engagements.

TypeDirect peer
Description

Independent European consulting firm providing market access, HTA and pricing services to pharma and medtech. Comparable boutique competitor in size and European focus, often bidding against Medvance on EU market access work.

TypeDirect peer
Description

European specialist market access and pricing consultancy focused on pharma and medtech across EU markets. Highly comparable boutique competitor to Medvance with similar customer verticals and cross-country delivery model.

TypeDirect peer
Description

Global market access and pricing consultancy with strong European presence, providing HTA, health economics and value communication services. Directly comparable in customer base, service offering and EU market focus.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Medvance

Healthcare Market Access Consultingmedvance.eu

Medvance is a European healthcare consultancy group providing market access and public affairs services to pharmaceutical, biotechnology, and medical device companies across nine European countries via an integrated network of locally grounded member firms.

What Medvance does

Medvance is a European healthcare consultancy group headquartered in Paris, France, providing market access and public affairs services to pharmaceutical, biotechnology, and medical device companies. Founded in 2017 and operating under the French SARL legal entity Nextep (established 1999 by Guillaume Bouchara), the firm is structured as an integrated network of locally grounded member firms spanning nine European markets: France, Italy, the United Kingdom, Germany, Spain, Belgium, Portugal, the Netherlands, and Luxembourg. The 80-person team enables clients to contract with MEDVANCE as a single legal entity while accessing country-specific expertise through member firms including Nextep (France), Intexo Società Benefit (Italy), and Remap Consulting (UK).

The company delivers two core service lines. Market Access Services encompass European HTA support, strategic pricing advice, local HTA submission and negotiation, reimbursement submissions, health economics analyses (systematic literature reviews, network meta-analyses), clinical engagement, advisory board facilitation, payer research, real-world data studies, and medical writing. Public Affairs Services cover health policy advocacy, political influencing, patient advocacy, stakeholder outreach, campaign and coalition building, and policy intelligence and monitoring. Delivery is anchored by senior partners with 20+ years of healthcare experience, including prior roles at Pfizer, Ferring Pharmaceuticals, GSK, IMS Consulting, and Ambrosetti.

Medvance generates revenue through professional services consulting engagements on a B2B quote-based pricing model, selling to enterprise clients across pharmaceutical, biotech, and medical device verticals. The go-to-market motion is direct enterprise field sales, supplemented by thought leadership at industry conferences (ISPOR Europe, BIO International), peer-reviewed publications and posters, and a LinkedIn presence. The firm is privately held with no disclosed external funding or M&A activity in the input data.

Medvance firmographics

Firmographics
Name
Medvance
Legal name
Nextep
Website
https://medvance.eu
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
Medvance is a European healthcare consultancy group providing market access and public affairs services to pharmaceutical, biotechnology, and medical device companies across nine European countries via an integrated network of locally grounded member firms.
Ownership category
akta.pro rank

Medvance industry classification

Industry
Product category
Healthcare Market Access Consulting
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYHLAIAKAL
Access Policy, Advocacy & Stakeholder Management
Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Market Access and Pricing

Keywords

  • Healthcare market access
  • Pharmaceutical consulting
  • HTA support services
  • Public affairs consulting
  • Reimbursement strategy

Where Medvance is headquartered

Location

Headquarters

HQ city
Paris
HQ country
France
HQ region
Europe

Offices1 record

Markets served

Medvance business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Professional Services Consulting: Provides consulting services for market access, HTA support, pricing advice, and public affairs for pharmaceutical, biotech and medical device companies across European markets.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Medvance product offering

Product offering

Core offering

Medvance is a European-wide consultancy group providing market access and public affairs consulting services to pharmaceutical, biotechnology and medical device companies. Market Access services cover European HTA support, access strategy, pricing advice, reimbursement submission, health economics, systematic literature review, network meta-analysis and real world data studies. Public Affairs services cover health policy advocacy, campaign building, patient advocacy and stakeholder outreach across nine European markets through a network of locally grounded member firms.

Product overview

Medvance is a European-wide consultancy group that offers two primary service offerings: Market Access Services and Public Affairs Services. The Market Access Services provide comprehensive support including European HTA support, strategic pricing advice, reimbursement submission, health economics, and real world data studies. The Public Affairs Services focus on health policy, political influencing, patient advocacy, and stakeholder outreach. These services work together to address the market access and public affairs needs of pharmaceutical, biotech, and medical devices companies across European markets.

Differentiator

Problem solved

Functional benefit

Products and services

  • Market Access Services

Companies that use Medvance

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Medvance technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Medvance partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • NextepcoreOthersParent legal entity and founding member of MEDVANCE. Based in Paris, provides market access and public affairs consultancy services. Guillaume Bouchara founded Nextep in 1999 and serves as Publication Director.
  • Intexo Società BenefitcoreOthersItalian member firm of MEDVANCE network. Mariangela Prada serves as CEO and Partner at Intexo, bringing 20 years of healthcare market access experience.
  • Remap ConsultingcoreOthersUK-based member firm. Graham Foxon co-founded Remap Consulting in 2014, specializing in pricing, health economics and market access optimization with over 20 years pharmaceutical experience.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Medvance competitors and assessment

Company assessment

Direct peers

  • Putnam Associates: Specialist consulting firm focused exclusively on biopharma market access, pricing and commercial strategy. Highly comparable to Medvance in service scope and customer base, with deeper US presence and similar EU mid-cap client focus.
  • Valid Insight: UK-based market access and pricing consultancy serving pharma, biotech and medtech with EU and global coverage. Direct niche peer competing for the same HTA, pricing and value communication mandates Medvance serves.
  • CBPartners: Specialist pricing, market access and HEOR consultancy serving pharma and biotech globally. Closely comparable service mix to Medvance, with comparable scale and a similar focus on cross-border pricing and HTA strategy engagements.
  • LSC Life Sciences Consultants: Independent European consulting firm providing market access, HTA and pricing services to pharma and medtech. Comparable boutique competitor in size and European focus, often bidding against Medvance on EU market access work.
  • Dolon: European specialist market access and pricing consultancy focused on pharma and medtech across EU markets. Highly comparable boutique competitor to Medvance with similar customer verticals and cross-country delivery model.
  • PRMA Consulting: Global market access and pricing consultancy with strong European presence, providing HTA, health economics and value communication services. Directly comparable in customer base, service offering and EU market focus.

Broad incumbents

  • Charles River Associates (CRA): CRA's Life Sciences practice provides pricing, market access, HEOR and commercial strategy to global pharma. A direct competitor for EU HTA and pricing engagements, though CRA covers a broader range of industries and services beyond healthcare.
  • Evidera: PPD/Evidera is a dedicated HEOR, market access and real-world evidence consultancy serving pharma and biotech across Europe and globally. Directly competes with Medvance on HTA submissions, HEOR modeling and RWE studies, now operating under Thermo Fisher.
  • McKinsey & Company (Pharma Practice): Top-tier strategy consultancy with a dedicated pharma/biotech practice advising on market access, pricing and public affairs at the executive level. Larger and broader than Medvance, but competes for the same senior pharma strategy budgets.
  • IQVIA: Global CRO and healthcare consulting giant offering HEOR, market access, HTA and real-world evidence services to pharma. Overlaps directly with Medvance's market access offering but as part of a much broader portfolio spanning clinical, commercial and technology services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Medvance social profiles

Digital presence

Medvance compliance and trust

Trust signal

Compliance2 records

Medvance financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Medvance leadership team

Management profile

Number of profiles

Profiles3 records

Medvance funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Medvance M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medvance

What does Medvance do?

Medvance is a European-wide consultancy group providing market access and public affairs consulting services to pharmaceutical, biotechnology and medical device companies. Market Access services cover European HTA support, access strategy, pricing advice, reimbursement submission, health economics, systematic literature review, network meta-analysis and real world data studies. Public Affairs services cover health policy advocacy, campaign building, patient advocacy and stakeholder outreach across nine European markets through a network of locally grounded member firms.

Is Medvance a public or private company?

Medvance is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Medvance founded?

Medvance was founded in 2017. It employs 11 to 50 people.

Where is Medvance based?

Medvance is headquartered in Paris, France, in the Europe region.

How does Medvance make money?

One revenue line is on record: professional Services Consulting.

Who are Medvance's main competitors?

Direct peers on record are Putnam Associates, Valid Insight, CBPartners, LSC Life Sciences Consultants, Dolon and PRMA Consulting. Broad incumbents are Charles River Associates (CRA), Evidera, McKinsey & Company (Pharma Practice) and IQVIA.

Does Medvance have an API?

No public API is recorded for Medvance.

What industry is Medvance in?

Medvance's product category is Healthcare Market Access Consulting. Its primary akta.pro industry code is HLAIAKAL, Access Policy, Advocacy & Stakeholder Management. Its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales